Promising Test Results For Its Cancer Drugs Just Launched This Small Biotech To A Record High

On Monday, the small biotech stock highlighted in today’s article hit a record high, skyrocketing 95.1%. The catalyst? Promising test results for its breast and prostate cancer treatments – drugs that “send bad actor proteins to the cellular garbage disposal.” For more on this firm, its cancer drug candidates, and how analysts are responding to the tests results, CLICK HERE.